Home › Phenylketonuria › Illinois
Phenylketonuria clinical trials in Illinois
6 studies for Phenylketonuria are looking for participants at sites in Illinois.
Cities in Illinois
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07477691A Study of MZE782 in Adults With PKU
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT07694440A Study of JNT-517 in Participants With Phenylketonuria (PKU)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 3
Ages 4 and older · All sexes · Updated Oct 21, 2026 · NCT06971731PheCheck™ Validation Study
- Lurie Children's Hospital, Chicago
RecruitingObservational study
Ages 1 and older · All sexes · Updated Aug 25, 2026 · NCT07551921A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
- Northwestern University, Chicago
RecruitingObservational study
All ages · All sexes · Updated Mar 25, 2026 · NCT05813678A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
- Northwestern University, Chicago
RecruitingObservational study
All ages · All sexes · Updated Mar 24, 2026 · NCT06305234From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.